In modern oncology, patient empowerment and equitable care are as critical as clinical treatment. Education, Patient Advocacy & Equity are central to ensuring that patients and caregivers are well-informed about disease management, treatment options, and available resources. Comprehensive education initiatives help individuals make informed decisions, adhere to treatment plans, and navigate the complexities of cancer care. Patient advocacy strengthens the voice of those affected, promoting policies and practices that prioritize patient needs, improve access to therapies, and support participation in clinical trials. Health equity efforts aim to reduce disparities in care delivery, ensuring that every patient receives high-quality treatment regardless of socioeconomic status, ethnicity, or geographic location.
The integration of Education, Patient Advocacy & Equity extends beyond information-sharing to actionable strategies that foster inclusivity and empowerment. Oncology teams collaborate with advocacy organizations to develop culturally sensitive educational programs, provide access to supportive services, and address systemic barriers to care. Policies that promote equitable access to diagnostics, therapies, and survivorship programs are critical for improving outcomes across diverse populations. By embedding education, advocacy, and equity into standard oncology practice, healthcare providers can enhance patient engagement, optimize treatment adherence, and support holistic, patient-centered care that benefits all individuals affected by cancer.
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : Integrating single-cell and spatial transcriptomics to uncover and elucidate GP73-mediated pro-angiogenic regulatory networks in hepatocellular carcinoma
Jiazhou Ye, Guangxi Medical University Cancer Hospital, China
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Spatial multi-omics inference of diabetes-triggered pancreatic cancer growth: The key role of cholesterol-induced neutrophil extracellular
Guanqun Li, The First Affiliated Hospital of Harbin Medical University, China
Title : Analysis of the dynamic evolution and influencing factors of nutritional risk in breast cancer patients during treatment
Jingwen Yan, Sun Yat-sen University, China
Title : Multiplexed biosensor detection of cancer biomarkers
Michael Thompson, University of Toronto, Canada